Stock listing

Imunon, Inc.

Selected listing: IMNN · NASDAQ · USD · US

Imunon, Inc. (NASDAQ:IMNN), Health Technology. Latest release Sep 29, 2026: IMUNON Converts $1.2 Million of Debt-to-Equity.

IMNN:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:IMNN
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: NASDAQ
Currency: USD

About Imunon, Inc.

Imunon, Inc. is a public company traded under the ticker IMNN in the American market. Imunon focuses on developing innovative therapies in the healthcare sector.

Latest news from Imunon, Inc.

IMUNON Converts $1.2 Million of Debt-to-Equity

September 28, 2026

IMUNON Reports Independent Data Monitoring Committee Recommends Continued Phase 2 Development of IMNN-001 Following Favorable Safety Review

September 22, 2026

IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001

September 10, 2026

IMUNON Announces Full Agenda and Speaker Lineup Ahead of 2026 R&D Day Highlighting IMNN-001 Clinical Progress

September 9, 2026

IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001

August 26, 2026

All Imunon, Inc. news →

Events

Replays

Imunon, Inc. (IMNN) Q2 2026 Earnings Call
Tue, Aug 11, 2026 · 11:00 AM ET
Watch
Imunon, Inc. (IMNN) Q1 2026 Earnings Call
Tue, May 12, 2026 · 11:00 AM ET
Watch
Imunon, Inc. (IMNN) Q4 2025 Earnings Call
Tue, Mar 31, 2026 · 11:00 AM ET
Watch

Research Imunon, Inc.

Imunon, Inc. company profile

View the public company page for Imunon, Inc. on 6ix.

Imunon, Inc. news

Read company news and market updates connected to Imunon, Inc..

Imunon, Inc. investor events

Find investor webinars, events, and replay context for Imunon, Inc..